Orion Oyj

Orion Oyj is a globally operating pharmaceutical enterprise engaged in the research, development, manufacturing, and marketing of medicines for both human and animal health, alongside active pharmaceutical ingredients (APIs). Its commercial footprint spans Finland, Scandinavia, other European countries, North America, and numerous international markets. The company's human health portfolio encompasses a variety of prescription drugs and self-care products.

Prominent prescription therapies include Nubeqa for prostate cancer; Dexdor and Precedex, utilized as intensive care sedatives; Stalevo and Comtess/Comtan for Parkinson's disease; Simdax for acute decompensated heart failure; and Fareston for breast cancer.

Orion also provides a line of Easyhaler devices, delivering medications such as Salmeterol/fluticasone, Budesonide/formoterol, Formoterol, Budesonide, Beclomet, and Buventol, which are prescribed for the treatment of asthma and chronic obstructive pulmonary disease.